DOI: 10.1055/s-00029025

Journal of Pediatric Epilepsy

Referenz

Arzimanoglou A, Ferreira JA, Satlin A. et al.
Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: an interim analysis from a multicenter, randomized, active-controlled, open-label study.

Eur J Paediatr Neurol 2016;
20 (03) 393-402

Bibliographische Angaben herunterladen

Aufrufen in:
Aufrufen in: